DOI:
10.1055/s-00000088
TumorDiagnostik & Therapie
LinksClose Window
References
Motzer RJ, Escudier B, Powles T. et al.
Long-term follow-up of overall survival for cabozantinib versus everolimus in advanced renal cell carcinoma.
Br J Cancer 2018;
118: 1176-1178
We do not assume any responsibility for the contents of the web pages of other providers.